Literature DB >> 17058721

Gallbladder management during laparoscopic Roux-en-Y gastric bypass surgery: routine preoperative screening for gallstones and postoperative prophylactic medical treatment are not necessary.

Kevin R Patel1, S C White, Talar Tejirian, Soo H Han, Doug Russell, Darshai Vira, Lingchen Liao, Karina B Patel, Carlos Gracia, Phillip Haigh, Erik Dutson, Amir Mehran.   

Abstract

In the bariatric surgery literature, the optimum approach to the gallbladder is controversial. Recommendations range from concomitant cholecystectomy to selective screening and postoperative medical prophylaxis. At our institution, we have taken a highly selective approach where patients are not routinely screened for gallstones, nor are they medically treated postoperatively with bile salts. We have reviewed our experience with this approach. From January 2003 to January 2005, 407 laparoscopic Roux en Y gastric bypasses were performed at UCLA and postoperative outcomes were collected into a prospective database. Exclusion criteria included previous cholecystectomy, a follow-up period less than 6 months, or incomplete records. One hundred ninety-nine patients were included in the study. With a mean follow up period of 17.8 months, 12 (6%) patients required cholecystectomy for gallstone-induced pathology. Laparoscopic removal was performed in 11 (92%) patients. Indications for surgery included acute cholecystitis in five (2.5%) patients, gallstone pancreatitis in two (1%) patients, and biliary colic alone in another five (2.5%) patients. The incidence of symptomatic gallstones requiring cholecystectomy after laparoscopic Roux en Y gastric bypass is low. These results are similar to those from institutions where routine preoperative screening and prophylactic postoperative medical therapy is used. Routine preoperative screening or medical prophylaxis may not be necessary.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17058721

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  20 in total

1.  Safety of laparoscopic adjustable gastric banding with concurrent cholecystectomy for symptomatic cholelithiasis.

Authors:  Nabeel R Obeid; Marina S Kurian; Christine J Ren-Fielding; George A Fielding; Bradley F Schwack
Journal:  Surg Endosc       Date:  2014-08-27       Impact factor: 4.584

2.  Early changes in postprandial gallbladder emptying in morbidly obese patients undergoing Roux-en-Y gastric bypass: correlation with the occurrence of biliary sludge and gallstones.

Authors:  Michel Bastouly; Carlos Haruo Arasaki; Jael Brasil Ferreira; Arnaldo Zanoto; Fabíola Gouveia H P Borges; José Carlos Del Grande
Journal:  Obes Surg       Date:  2008-08-12       Impact factor: 4.129

3.  Prevalence of Cholelithiasis and Choledocholithiasis in Morbidly Obese South Indian Patients and the Further Development of Biliary Calculus Disease After Sleeve Gastrectomy, Gastric Bypass and Mini Gastric Bypass.

Authors:  Tapas Mishra; Kona Kumari Lakshmi; Kiran Kumar Peddi
Journal:  Obes Surg       Date:  2016-10       Impact factor: 4.129

4.  The evaluation of gallstone formation in patients undergoing Roux-en-Y gastric bypass due to morbid obesity.

Authors:  Metin Karadeniz; Mehmet Görgün; Cemal Kara
Journal:  Ulus Cerrahi Derg       Date:  2014-06-01

5.  Prophylactic cholecystectomy, a mandatory step in morbidly obese patients undergoing laparoscopic Roux-en-Y gastric bypass?

Authors:  Mathieu D'Hondt; Gregory Sergeant; Bert Deylgat; Dirk Devriendt; Frank Van Rooy; Franky Vansteenkiste
Journal:  J Gastrointest Surg       Date:  2011-07-13       Impact factor: 3.452

6.  Is routine cholecystectomy justified in severely obese patients undergoing a laparoscopic Roux-en-Y gastric bypass procedure? A comparative cohort study.

Authors:  Ignazio Tarantino; Renè Warschkow; Thomas Steffen; Philipp Bisang; Bernd Schultes; Martin Thurnheer
Journal:  Obes Surg       Date:  2011-12       Impact factor: 4.129

Review 7.  Concomitant cholecystectomy during laparoscopic Roux-en-Y gastric bypass in obese patients is not justified: a meta-analysis.

Authors:  Rene Warschkow; Ignazio Tarantino; Kristjan Ukegjini; Ulrich Beutner; Ulrich Güller; Bruno M Schmied; Sascha A Müller; Bernd Schultes; Martin Thurnheer
Journal:  Obes Surg       Date:  2013-03       Impact factor: 4.129

8.  Is routine cholecystectomy indicated for asymptomatic cholelithiasis in patients undergoing gastric bypass?

Authors:  William Fuller; Jason J Rasmussen; Jagannath Ghosh; Mohamed R Ali
Journal:  Obes Surg       Date:  2007-06       Impact factor: 4.129

9.  Is concomitant cholecystectomy necessary in obese patients undergoing laparoscopic gastric bypass surgery?

Authors:  O N Tucker; P Fajnwaks; S Szomstein; R J Rosenthal
Journal:  Surg Endosc       Date:  2008-02-21       Impact factor: 4.584

10.  Risk of Biliary Events After Selective Cholecystectomy During Biliopancreatic Diversion with Duodenal Switch.

Authors:  Iswanto Sucandy; Moaz Abulfaraj; Mary Naglak; Gintaras Antanavicius
Journal:  Obes Surg       Date:  2016-03       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.